Nevro Corp. (NYSE:NVRO) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET

Company Participants

Greg Chodaczek - Gilmartin Group LLC

Kevin Thornal - President and CEO

Rod MacLeod - Chief Financial Officer

Conference Call Participants

Anthony Petrone - Mizuho Group

Simran Kaur - Piper Sandler

Nathan Treybeck - Wells Fargo

Allen Gong - JPMorgan

Brandon Vazquez - William Blair

Brad Bowers - Mizuho Securities

David Turkaly - JMP Securities

Operator

Ladies and gentlemen, good afternoon. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to Nevro's Second Quarter 2023 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]

And I would now like to turn the call over to Greg Chodaczek for introductory remarks. Please go ahead.

Greg Chodaczek

Thanks, Abby. Good afternoon. And welcome to Nevro's second quarter 2023 earnings conference call. With me today are Kevin Thornal, CEO and President; and Rod MacLeod, Chief Financial Officer.

On today's Kevin will discuss second quarter business results. And Rod will conclude with detailed financials and guidance before we open it up -- open up the call for questions.

Please note, there are also slides available related to our Nevro's second quarter performance on the Investor Relations website in the Events & Presentations section. Earlier today Nevro released its financial results for the second quarter ended June 30, 2023. A copy of our earnings release is available on our Investor Relations section of Nevro's website at nevro.com. This call is being broadcast live over the Internet to all interested parties on August 1, 2023 and an archived copy of this webcast will be available on Nevro's Investor Relations website.

Before we begin, I'd like to remind everyone that comments made on today's call may include forward-looking statements within the meaning of the federal securities laws. Results could differ materially from those expressed or implied as a result of certain risks and uncertainties. Please refer to Nevro's SEC filings including the annual report on Form 10-K filed on February 21, 2023 for a detailed presentation of risks. The forward-looking statements in this call speak only as of today, and the company undertakes no obligation to update or revise any of these statements.

In addition, management will refer to adjusted EBITDA, a non-GAAP measure used to help investors understand Nevro’s ongoing business performance. Non-GAAP adjusted EBITDA excludes interest, taxes and non-cash items such as stock-based compensation, and depreciation and amortization, as well as litigation-related expenses, certain litigation charges and credits and other adjustments, such as restructuring charges. Please refer to the GAAP to non-GAAP reconciliation tables within the earnings release.